Signati Medical
Private Company
Funding information not available
Overview
Signati Medical is a pre-revenue, private medical device startup focused on the male contraception market. Its lead product is the Sealed Vasectomy Procedure (SVP), a bipolar electrosurgical device and technique aimed at making vasectomies faster for physicians and more comfortable for patients, with the goal of enabling in-office procedures and easier recovery. The company has assembled a strong Clinical Advisory Board of prominent urologists and andrologists but has not yet launched commercially, indicating it is in a late-stage development or pre-launch phase. Signati operates in a large, established market with limited recent innovation, presenting a significant opportunity if it can successfully demonstrate clinical and commercial advantages over existing techniques.
Technology Platform
Bipolar electrosurgical platform for sealing the vas deferens during vasectomy, designed for speed, patient comfort, and in-office use.
Opportunities
Risk Factors
Competitive Landscape
Competition includes traditional vasectomy techniques using scalpels, clips, and cautery, which are low-cost and well-established. Other medical device companies may offer specialized vasectomy kits, but Signati claims to be the first major innovation in decades, positioning its bipolar sealing technology as a potential differentiator in procedure speed and recovery.